-
1
-
-
0013218415
-
-
Bates G, Harper P, Jones L, editors New York: Oxford University Press
-
Bates G, Harper P, Jones L, editors. Huntington's Disease. 3rd ed. New York: Oxford University Press; (2002).
-
(2002)
Huntington's Disease. 3rd Ed.
-
-
-
2
-
-
0024450903
-
The functional anatomy of basal ganglia disorders
-
Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:366-375 (1989).
-
(1989)
Trends Neurosci.
, vol.12
, pp. 366-375
-
-
Albin, R.L.1
Young, A.B.2
Penney, J.B.3
-
5
-
-
0022395922
-
Neuropathological classification of Huntington's disease
-
Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577 (1985).
-
(1985)
J Neuropathol Exp Neurol
, vol.44
, pp. 559-577
-
-
Vonsattel, J.P.1
Myers, R.H.2
Stevens, T.J.3
Ferrante, R.J.4
Bird, E.D.5
Richardson, E.P.6
-
6
-
-
0025885733
-
Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease
-
Hedreen JC, Peyser CE, Folstein SE, Ross CA. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257-261 (1991).
-
(1991)
Neurosci Lett
, vol.133
, pp. 257-261
-
-
Hedreen, J.C.1
Peyser, C.E.2
Folstein, S.E.3
Ross, C.A.4
-
8
-
-
0023007832
-
Neuropeptides in neurological disease
-
Beal MF, Martin JB. Neuropeptides in neurological disease. Ann Neurol 20(5):547-65 (1986).
-
(1986)
Ann Neurol
, vol.20
, Issue.5
, pp. 547-565
-
-
Beal, M.F.1
Martin, J.B.2
-
9
-
-
0001589776
-
Differential loss of striatal projection neurons in Huntington disease
-
Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 5733-5737 (1988).
-
(1988)
Proc Natl Acad Sci USA
, pp. 5733-5737
-
-
Reiner, A.1
Albin, R.L.2
Anderson, K.D.3
D'Amato, C.J.4
Penney, J.B.5
Young, A.B.6
-
10
-
-
0025276132
-
Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity-akinesia
-
Albin RL, Reiner A, Anderson KD, Penney JB, Young AB. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 27:357-365 (1990).
-
(1990)
Ann Neurol
, vol.27
, pp. 357-365
-
-
Albin, R.L.1
Reiner, A.2
Anderson, K.D.3
Penney, J.B.4
Young, A.B.5
-
11
-
-
0027480960
-
A novel gene containing a trinucleotide repeat that is unstable in Huntington's disease chromosomes
-
Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is unstable in Huntington's disease chromosomes. Cell 72:971-983 (1993).
-
(1993)
Cell
, vol.72
, pp. 971-983
-
-
-
12
-
-
0027240431
-
Trinucleotide repeat length instability and age of onset in Huntington's disease
-
Duyao MP, Ambrose CM, Myers RH, Novoletto A, Persichetti F, Frontali M, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 4:387-392 (1993).
-
(1993)
Nat Genet
, vol.4
, pp. 387-392
-
-
Duyao, M.P.1
Ambrose, C.M.2
Myers, R.H.3
Novoletto, A.4
Persichetti, F.5
Frontali, M.6
-
13
-
-
84993912315
-
Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue
-
Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 11:155-163 (1995).
-
(1995)
Nat Genet
, vol.11
, pp. 155-163
-
-
Zeitlin, S.1
Liu, J.P.2
Chapman, D.L.3
Papaioannou, V.E.4
Efstratiadis, A.5
-
14
-
-
0030613177
-
Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion
-
White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet 17(4):404-410 (1997).
-
(1997)
Nat Genet
, vol.17
, Issue.4
, pp. 404-410
-
-
White, J.K.1
Auerbach, W.2
Duyao, M.P.3
Vonsattel, J.P.4
Gusella, J.F.5
Joyner, A.L.6
-
15
-
-
0034639717
-
Huntingtin is required for normal hematopoiesis
-
Metzler M, Helgason CD, Dragatsis I, Zhang T, Gan L, Pineault N, et al. Huntingtin is required for normal hematopoiesis. Hum Mol Genet 9(3):387-94 (2000).
-
(2000)
Hum Mol Genet
, vol.9
, Issue.3
, pp. 387-394
-
-
Metzler, M.1
Helgason, C.D.2
Dragatsis, I.3
Zhang, T.4
Gan, L.5
Pineault, N.6
-
16
-
-
0035805504
-
Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing
-
Rigamonti D, Sipione S, Goffredo D, Zuccato C, Fossale E, Cattaneo E. Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. J Biol Chem 276(18):14545-8 (2001).
-
(2001)
J Biol Chem
, vol.276
, Issue.18
, pp. 14545-14548
-
-
Rigamonti, D.1
Sipione, S.2
Goffredo, D.3
Zuccato, C.4
Fossale, E.5
Cattaneo, E.6
-
17
-
-
0035816627
-
Polyglutamine-expanded huntingtin promotes sensitization of N-Methyl-D-aspartate receptors via post-synaptic density 95
-
Sun Y, Savanenin A, Reddy PH, Liu YF. Polyglutamine-expanded huntingtin promotes sensitization of N-Methyl-D-aspartate receptors via post-synaptic density 95. J Biol Chem 276(27):24713-24718 (2001).
-
(2001)
J Biol Chem
, vol.276
, Issue.27
, pp. 24713-24718
-
-
Sun, Y.1
Savanenin, A.2
Reddy, P.H.3
Liu, Y.F.4
-
18
-
-
0036500862
-
Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: Relevance to Huntington's disease
-
Hoffner G, Kahlem P, Djian P. Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. J Cell Sci 115(Pt 5):941-8 (2002).
-
(2002)
J Cell Sci
, vol.115
, Issue.5 PART
, pp. 941-948
-
-
Hoffner, G.1
Kahlem, P.2
Djian, P.3
-
19
-
-
0028989602
-
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
-
DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14(5):1075-81 (1995).
-
(1995)
Neuron
, vol.14
, Issue.5
, pp. 1075-1081
-
-
DiFiglia, M.1
Sapp, E.2
Chase, K.3
Schwarz, C.4
Meloni, A.5
Young, C.6
-
20
-
-
0028220405
-
Trinucleotide repeats in neurological diseases: An hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I
-
Cha JJ, Dure LS, IV. Trinucleotide repeats in neurological diseases: an hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I. Life Sci. 54:1459-1464 (1994).
-
(1994)
Life Sci
, vol.54
, pp. 1459-1464
-
-
Cha, J.J.1
Dure IV, L.S.2
-
21
-
-
0029968460
-
Trinucleotide repeats in neurogenetic disorders
-
Paulson HL, Fischbeck KH. Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 19:79-107 (1996).
-
(1996)
Annu Rev Neurosci
, vol.19
, pp. 79-107
-
-
Paulson, H.L.1
Fischbeck, K.H.2
-
22
-
-
0002538312
-
Huntington's disease and other trinucleotide repeat disorders
-
Martin JB, editor. New York: Scientific American, Inc.
-
Young AB. Huntington's disease and other trinucleotide repeat disorders. In: Martin JB, editor. Scientific American Molecular Neurology. New York: Scientific American, Inc.; p. 35-54 (1998).
-
(1998)
Scientific American Molecular Neurology
, pp. 35-54
-
-
Young, A.B.1
-
23
-
-
0033614776
-
Polyglutamine pathogenesis
-
Ross CA, Wood JD, Schilling G, Peters MF, Nucifora FC Jr, Cooper JK, et al. Polyglutamine pathogenesis. Philos Trans R Soc Lond B Biol Sci 354(1386):1005-11 (1999).
-
(1999)
Philos Trans R Soc Lond B Biol Sci
, vol.354
, Issue.1386
, pp. 1005-1011
-
-
Ross, C.A.1
Wood, J.D.2
Schilling, G.3
Peters, M.F.4
Nucifora Jr., F.C.5
Cooper, J.K.6
-
24
-
-
0025363346
-
Excitotoxic injury of the neostriatum: A model for Huntington's disease
-
DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci 13(7):286-289 (1990).
-
(1990)
Trends Neurosci
, vol.13
, Issue.7
, pp. 286-289
-
-
DiFiglia, M.1
-
25
-
-
33748472875
-
Evidence of bioenergetic defects in Huntington's disease post-mortem brain, and in a transgenic mouse model of Huntington's disease
-
Syndey, Australia; 1997
-
Browne SE, Bowling AC, MacGarvey U, White JK, MacDonald ME, Beal MF. Evidence of bioenergetic defects in Huntington's disease post-mortem brain, and in a transgenic mouse model of Huntington's disease. In: 17th International Meeting of the World Federation of Neurology Research Group on Huntington's Disease; 1997; Syndey, Australia; 1997. p. 16.
-
(1997)
17th International Meeting of the World Federation of Neurology Research Group on Huntington's Disease
, pp. 16
-
-
Browne, S.E.1
Bowling, A.C.2
MacGarvey, U.3
White, J.K.4
MacDonald, M.E.5
Beal, M.F.6
-
26
-
-
0032504710
-
Mitochondrial dysfunction in neurodegenerative diseases
-
Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta Bio Energetics 1366(1-2):211-223 (1998).
-
(1998)
Biochim Biophys Acta Bio Energetics
, vol.1366
, Issue.1-2
, pp. 211-223
-
-
Beal, M.F.1
-
27
-
-
0033914747
-
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy
-
Lodi R, Schapira AH, Manners D, Styles P, Wood NW, Taylor DJ, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann. Neurol 48(1):72-6 (2000).
-
(2000)
Ann Neurol
, vol.48
, Issue.1
, pp. 72-76
-
-
Lodi, R.1
Schapira, A.H.2
Manners, D.3
Styles, P.4
Wood, N.W.5
Taylor, D.J.6
-
28
-
-
33748441075
-
Biochemical abnormalities in Huntington's disease brain
-
Syndey, Australia; 1997
-
Schapira AHV, Tabrizi SJ, Cleeter M, Xuereb J, Cooper JM. Biochemical abnormalities in Huntington's disease brain. In: 17th International Meeting of the World Federation of Neurology Research Group on Huntington's Disease; 1997; Syndey, Australia; 1997. p. 16.
-
(1997)
17th International Meeting of the World Federation of Neurology Research Group on Huntington's Disease
, pp. 16
-
-
Schapira, A.H.V.1
Tabrizi, S.J.2
Cleeter, M.3
Xuereb, J.4
Cooper, J.M.5
-
29
-
-
0027433553
-
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionaic acid
-
Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionaic acid. J Neurosci 13:4181-4192 (1993).
-
(1993)
J Neurosci
, vol.13
, pp. 4181-4192
-
-
Beal, M.F.1
Brouillet, E.2
Jenkins, B.G.3
Ferrante, R.J.4
Kowall, N.W.5
Miller, J.M.6
-
30
-
-
0027448161
-
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
-
Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, et al. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 60:356-359 (1993).
-
(1993)
J Neurochem
, vol.60
, pp. 356-359
-
-
Brouillet, E.1
Jenkins, B.G.2
Hyman, B.T.3
Ferrante, R.J.4
Kowall, N.W.5
Srivastava, R.6
-
31
-
-
0033587128
-
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
-
Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease [see comments]. Nature 399(6733): 263-7 (1999).
-
(1999)
Nature
, vol.399
, Issue.6733
, pp. 263-267
-
-
Ona, V.O.1
Li, M.2
Vonsattel, J.P.3
Andrews, L.J.4
Khan, S.Q.5
Chung, W.M.6
-
32
-
-
0032502715
-
Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
-
Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273(15):9158-9167 (1998).
-
(1998)
J Biol Chem
, vol.273
, Issue.15
, pp. 9158-9167
-
-
Wellington, C.L.1
Ellerby, L.M.2
Hackam, A.S.3
Margolis, R.L.4
Trifiro, M.A.5
Singaraja, R.6
-
33
-
-
0033103523
-
Caspase-8 is required for cell death induced by expanded polyglutamine repeats
-
Sanchez I, Xu CJ, Juo P, Kakizaka A, Blenis J, Yuan J. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22(3):623-33 (1999).
-
(1999)
Neuron
, vol.22
, Issue.3
, pp. 623-633
-
-
Sanchez, I.1
Xu, C.J.2
Juo, P.3
Kakizaka, A.4
Blenis, J.5
Yuan, J.6
-
34
-
-
0034657112
-
Wild-type huntingtin protects from apoptosis upstream of caspase-3
-
Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, et al. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20(10):3705-3713 (2000).
-
(2000)
J Neurosci
, vol.20
, Issue.10
, pp. 3705-3713
-
-
Rigamonti, D.1
Bauer, J.H.2
De-Fraja, C.3
Conti, L.4
Sipione, S.5
Sciorati, C.6
-
35
-
-
18544410106
-
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
-
Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90(3):537-48 (1997).
-
(1997)
Cell
, vol.90
, Issue.3
, pp. 537-548
-
-
Davies, S.W.1
Turmaine, M.2
Cozens, B.A.3
DiFiglia, M.4
Sharp, A.H.5
Ross, C.A.6
-
36
-
-
0031446233
-
Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
-
Ross CA. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19:1147-1150 (1997).
-
(1997)
Neuron
, vol.19
, pp. 1147-1150
-
-
Ross, C.A.1
-
37
-
-
0034307476
-
Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy
-
Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, Aronin N, et al. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20(19):7268-78 (2000).
-
(2000)
J Neurosci
, vol.20
, Issue.19
, pp. 7268-7278
-
-
Kegel, K.B.1
Kim, M.2
Sapp, E.3
McIntyre, C.4
Castano, J.G.5
Aronin, N.6
-
38
-
-
0035364748
-
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
-
Petersen A, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P, et al. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet 10(12):1243-54 (2001).
-
(2001)
Hum Mol Genet
, vol.10
, Issue.12
, pp. 1243-1254
-
-
Petersen, A.1
Larsen, K.E.2
Behr, G.G.3
Romero, N.4
Przedborski, S.5
Brundin, P.6
-
39
-
-
0032568517
-
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
-
Cha J-HJ, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci USA 95:6480-6485 (1998).
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6480-6485
-
-
Cha, J.-H.J.1
Kosinski, C.M.2
Kerner, J.A.3
Alsdorf, S.A.4
Mangiarini, L.5
Davies, S.W.6
-
40
-
-
0034283877
-
Transcriptional dysregulation in Huntington's disease
-
Cha J-HJ. Transcriptional dysregulation in Huntington's disease. Trends Neurosci 23:387-392 (2000).
-
(2000)
Trends Neurosci
, vol.23
, pp. 387-392
-
-
Cha, J.-H.J.1
-
41
-
-
12944263711
-
The Huntington's disease protein interacts with p53 and CBP and represses transcription
-
Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu Y-Z, Gohler H, et al. The Huntington's disease protein interacts with p53 and CBP and represses transcription. Proc Natl Acad Sci USA 97:6763-6768 (2000).
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 6763-6768
-
-
Steffan, J.S.1
Kazantsev, A.2
Spasic-Boskovic, O.3
Greenwald, M.4
Zhu, Y.-Z.5
Gohler, H.6
-
42
-
-
0037408279
-
Transcriptional abnormalities in Huntington disease
-
Sugars KL, Rubinsztein DC. Transcriptional abnormalities in Huntington disease. Trends Genet 19(5):233-8 (2003).
-
(2003)
Trends Genet
, vol.19
, Issue.5
, pp. 233-238
-
-
Sugars, K.L.1
Rubinsztein, D.C.2
-
43
-
-
0037101835
-
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: Parallel changes in muscle and brain
-
Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, et al. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11:1911-1926 (2002).
-
(2002)
Hum Mol Genet
, vol.11
, pp. 1911-1926
-
-
Luthi-Carter, R.1
Hanson, S.A.2
Strand, A.D.3
Bergstrom, D.A.4
Chun, W.5
Peters, N.L.6
-
44
-
-
0141828353
-
Mechanisms of transcriptional dysregulation in Huntington's disease
-
Luthi-Carter R, Cha J-HJ. Mechanisms of transcriptional dysregulation in Huntington's disease. Clin Neurosci Res 3:165-177 (2003).
-
(2003)
Clin Neurosci Res
, vol.3
, pp. 165-177
-
-
Luthi-Carter, R.1
Cha, J.-H.J.2
-
45
-
-
23444458415
-
Transcriptional activation modulated by homopolymeric glutamine and proline stretches
-
Gerber HP, Seipel K, Georgiev O, Höfferer M, Hug M, Rusconi S, et al. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263:808-811 (1994).
-
(1994)
Science
, vol.263
, pp. 808-811
-
-
Gerber, H.P.1
Seipel, K.2
Georgiev, O.3
Höfferer, M.4
Hug, M.5
Rusconi, S.6
-
46
-
-
0029983147
-
Trinucleotide repeats and long homopeptides in genes and proteins associated with nervous system disease and development
-
Karlin S, Burge C. Trinucleotide repeats and long homopeptides in genes and proteins associated with nervous system disease and development. Proc Natl Acad Sci USA 93:1560-1565 (1996).
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 1560-1565
-
-
Karlin, S.1
Burge, C.2
-
47
-
-
0035937523
-
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
-
Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291(5512):2423-8 (2001).
-
(2001)
Science
, vol.291
, Issue.5512
, pp. 2423-2428
-
-
Nucifora Jr., F.C.1
Sasaki, M.2
Peters, M.F.3
Huang, H.4
Cooper, J.K.5
Yamada, M.6
-
48
-
-
0032450856
-
Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins
-
Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, MacDonald ME, et al. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol Genet 24(4):217-233 (1998).
-
(1998)
Somat Cell Mol Genet
, vol.24
, Issue.4
, pp. 217-233
-
-
Huang, C.C.1
Faber, P.W.2
Persichetti, F.3
Mittal, V.4
Vonsattel, J.P.5
MacDonald, M.E.6
-
49
-
-
0037150687
-
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
-
Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, et al . Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296(5576):2238-43 (2002).
-
(2002)
Science
, vol.296
, Issue.5576
, pp. 2238-2243
-
-
Dunah, A.W.1
Jeong, H.2
Griffin, A.3
Kim, Y.M.4
Standaert, D.G.5
Hersch, S.M.6
-
50
-
-
0035909330
-
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
-
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857): 739-43 (2001).
-
(2001)
Nature
, vol.413
, Issue.6857
, pp. 739-743
-
-
Steffan, J.S.1
Bodai, L.2
Pallos, J.3
Poelman, M.4
McCampbell, A.5
Apostol, B.L.6
-
51
-
-
0142157600
-
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice
-
Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23(28):9418-27 (2003).
-
(2003)
J Neurosci
, vol.23
, Issue.28
, pp. 9418-9427
-
-
Ferrante, R.J.1
Kubilus, J.K.2
Lee, J.3
Ryu, H.4
Beesen, A.5
Zucker, B.6
-
52
-
-
0037452775
-
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
-
Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 100:2041-2046 (2003).
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 2041-2046
-
-
Hockly, E.1
Richon, V.M.2
Woodman, B.3
Smith, D.L.4
Zhou, X.5
Rosa, E.6
-
53
-
-
19944431703
-
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
-
Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, et al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem 280(1):556-63 (2005).
-
(2005)
J Biol Chem
, vol.280
, Issue.1
, pp. 556-563
-
-
Gardian, G.1
Browne, S.E.2
Choi, D.K.3
Klivenyi, P.4
Gregorio, J.5
Kubilus, J.K.6
-
54
-
-
0030612119
-
Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease
-
Augood SJ, Faull RLM, Emson PC. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol 42:215-221 (1997).
-
(1997)
Ann Neurol
, vol.42
, pp. 215-221
-
-
Augood, S.J.1
Faull, R.L.M.2
Emson, P.C.3
-
55
-
-
0033614761
-
Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
-
Cha J-HJ, Frey AS, Alsdorf SA, Kerner JA, Kosinski CM, Mangiarini L, et al. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos Trans R Soc Lond B Biol Sci 354(1386):981-9 (1999).
-
(1999)
Philos Trans R Soc Lond B Biol Sci
, vol.354
, Issue.1386
, pp. 981-989
-
-
Cha, J.-H.J.1
Frey, A.S.2
Alsdorf, S.A.3
Kerner, J.A.4
Kosinski, C.M.5
Mangiarini, L.6
-
56
-
-
33744532300
-
Neurochemistry of Huntington's disease
-
Bates GP, Harper PS, Jones AL, editors. London: Oxford Medical Publications
-
Yohrling GJ, Cha J-HJ. Neurochemistry of Huntington's disease. In: Bates GP, Harper PS, Jones AL, editors. Huntington's Disease. 3rd ed. London: Oxford Medical Publications; 2002. p. 276-308.
-
(2002)
Huntington's Disease. 3rd Ed.
, pp. 276-308
-
-
Yohrling, G.J.1
Cha, J.-H.J.2
-
57
-
-
16044373842
-
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
-
Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506 (1996).
-
(1996)
Cell
, vol.87
, pp. 493-506
-
-
Mangiarini, L.1
Sathasivam, K.2
Seller, M.3
Cozens, B.4
Harper, A.5
Hetherington, C.6
-
58
-
-
0029895292
-
Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease
-
Weeks RA, Piccini P, Harding AE, Brooks DJ. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann Neurol 40:49-54 (1996).
-
(1996)
Ann Neurol
, vol.40
, pp. 49-54
-
-
Weeks, R.A.1
Piccini, P.2
Harding, A.E.3
Brooks, D.J.4
-
59
-
-
0034702030
-
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
-
Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet 9:1259-1271 (2000).
-
(2000)
Hum Mol Genet
, vol.9
, pp. 1259-1271
-
-
Luthi-Carter, R.1
Strand, A.2
Peters, N.L.3
Solano, S.M.4
Hollingsworth, Z.R.5
Menon, A.S.6
-
60
-
-
0034612255
-
Severe deficiencies in dopamine signaling in pre-symptomatic Huntington's disease mice
-
Bibb JA, Yan Z, Svenningsson P, Snyder GL, Pieribone VA, Horiuchi A, et al. Severe deficiencies in dopamine signaling in pre-symptomatic Huntington's disease mice. Proc Natl Acad Sci USA 97(12):6809-14 (2000).
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, Issue.12
, pp. 6809-6814
-
-
Bibb, J.A.1
Yan, Z.2
Svenningsson, P.3
Snyder, G.L.4
Pieribone, V.A.5
Horiuchi, A.6
-
61
-
-
10944265363
-
Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A
-
Hu H, McCaw EA, Hebb AL, Gomez GT, Denovan-Wright EM. Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A. Eur J Neurosci 20(12):3351-63 (2004).
-
(2004)
Eur J Neurosci
, vol.20
, Issue.12
, pp. 3351-3363
-
-
Hu, H.1
McCaw, E.A.2
Hebb, A.L.3
Gomez, G.T.4
Denovan-Wright, E.M.5
-
62
-
-
11244306357
-
Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice
-
McCaw EA, Hu H, Gomez GT, Hebb AL, Kelly ME, Denovan-Wright EM. Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice. Eur J Biochem 271(23-24):4909-20 (2004).
-
(2004)
Eur J Biochem
, vol.271
, Issue.23-24
, pp. 4909-4920
-
-
McCaw, E.A.1
Hu, H.2
Gomez, G.T.3
Hebb, A.L.4
Kelly, M.E.5
Denovan-Wright, E.M.6
-
63
-
-
0033054555
-
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
-
Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, et al . Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8(3):397-407 (1999).
-
(1999)
Hum Mol Genet
, vol.8
, Issue.3
, pp. 397-407
-
-
Schilling, G.1
Becher, M.W.2
Sharp, A.H.3
Jinnah, H.A.4
Duan, K.5
Kotzuk, J.A.6
-
64
-
-
0034610814
-
The language of covalent histone modifications
-
Strahl BD, Allis CD. The language of covalent histone modifications. Nature 403(6765):41-5 (2000).
-
(2000)
Nature
, vol.403
, Issue.6765
, pp. 41-45
-
-
Strahl, B.D.1
Allis, C.D.2
-
65
-
-
0035839136
-
Translating the histone code
-
Jenuwein T, Allis CD. Translating the histone code. Science 293:1074-1080 (2001).
-
(2001)
Science
, vol.293
, pp. 1074-1080
-
-
Jenuwein, T.1
Allis, C.D.2
-
67
-
-
0034765511
-
Histone deacetylase inhibitors as new cancer drugs
-
Marks PA, Richon VM, Breslow R, Rifkind RA. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 13(6):477-83 (2001).
-
(2001)
Curr Opin Oncol
, vol.13
, Issue.6
, pp. 477-483
-
-
Marks, P.A.1
Richon, V.M.2
Breslow, R.3
Rifkind, R.A.4
-
69
-
-
0037354555
-
Histone acetylation and gastrointestinal carcinogenesis
-
Yasui W, Oue N, Ono S, Mitani Y, Ito R, Nakayama H. Histone acetylation and gastrointestinal carcinogenesis. Ann N Y Acad Sci 983:220-31 (2003).
-
(2003)
Ann N Y Acad Sci
, vol.983
, pp. 220-231
-
-
Yasui, W.1
Oue, N.2
Ono, S.3
Mitani, Y.4
Ito, R.5
Nakayama, H.6
-
70
-
-
0034596309
-
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
-
Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92(15):1210-6 (2000).
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.15
, pp. 1210-1216
-
-
Marks, P.A.1
Richon, V.M.2
Rifkind, R.A.3
-
71
-
-
0034905872
-
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
-
Butler LM, Webb Y, Agus DB, Higgins B, Tolentino TR, Kutko MC, et al . Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res (4):962-70 (2001).
-
(2001)
Clin Cancer Res
, Issue.4
, pp. 962-970
-
-
Butler, L.M.1
Webb, Y.2
Agus, D.B.3
Higgins, B.4
Tolentino, T.R.5
Kutko, M.C.6
-
72
-
-
0034730127
-
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
-
Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 97(18):10014-9 (2000).
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, Issue.18
, pp. 10014-10019
-
-
Richon, V.M.1
Sandhoff, T.W.2
Rifkind, R.A.3
Marks, P.A.4
-
73
-
-
0036176617
-
Histone deacetylase inhibitors in cancer treatment
-
Vigushin DM, Coombes RC. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13(1):1-13 (2002).
-
(2002)
Anticancer Drugs
, vol.13
, Issue.1
, pp. 1-13
-
-
Vigushin, D.M.1
Coombes, R.C.2
-
74
-
-
0035031779
-
Polyglutamine and CBP: Fatal attraction?
-
McCampbell A, Fischbeck KH. Polyglutamine and CBP: fatal attraction? Nat Med 7(5):528-30 (2001).
-
(2001)
Nat Med
, vol.7
, Issue.5
, pp. 528-530
-
-
McCampbell, A.1
Fischbeck, K.H.2
-
75
-
-
0035818514
-
Altered transcription in yeast expressing expanded polyglutamine
-
Hughes RE, Lo RS, Davis C, Strand AD, Neal CL, Olson JM, et al. Altered transcription in yeast expressing expanded polyglutamine. Proc Natl Acad Sci USA 98(23):13201-6 (2001).
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.23
, pp. 13201-13206
-
-
Hughes, R.E.1
Lo, R.S.2
Davis, C.3
Strand, A.D.4
Neal, C.L.5
Olson, J.M.6
-
76
-
-
0037961686
-
Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation
-
Igarashi S, Morita H, Bennett KM, Tanaka Y, Engelender S, Peters MF, et al. Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation. Neuroreport 14(4):565-8 (2003).
-
(2003)
Neuroreport
, vol.14
, Issue.4
, pp. 565-568
-
-
Igarashi, S.1
Morita, H.2
Bennett, K.M.3
Tanaka, Y.4
Engelender, S.5
Peters, M.F.6
-
77
-
-
4544323749
-
Histone deacetylase inhibitors: Understanding a new wave of anticancer agents
-
Villar-Garea A, Esteller M. Histone deacetylase inhibitors: understanding a new wave of anticancer agents. Int J Cancer 112(2):171-8 (2004).
-
(2004)
Int J Cancer
, vol.112
, Issue.2
, pp. 171-178
-
-
Villar-Garea, A.1
Esteller, M.2
-
78
-
-
0020262168
-
beta-Adrenergic receptor induction in HeLa cells: Synergistic effect of 5-azacytidine and butyrate
-
Jahangeer S, Elliott RM, Henneberry RC. beta-Adrenergic receptor induction in HeLa cells: synergistic effect of 5-azacytidine and butyrate. Biochem Biophys Res Commun 108(4):1434-40 (1982).
-
(1982)
Biochem Biophys Res Commun
, vol.108
, Issue.4
, pp. 1434-1440
-
-
Jahangeer, S.1
Elliott, R.M.2
Henneberry, R.C.3
-
80
-
-
0038677606
-
Inhibition of Histone Deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic check point activation
-
Shin HJ, Baek KH, Jeon AH, Kin SJ, Jang, KL, Sung YC, et al. Inhibition of Histone Deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic check point activation. Oncogene 2003; 22(25): 3853-8.
-
(2003)
Oncogene
, vol.22
, Issue.25
, pp. 3853-3858
-
-
Shin, H.J.1
Baek, K.H.2
Jeon, A.H.3
Kin, S.J.4
Jang, K.L.5
Sung, Y.C.6
-
81
-
-
0028303870
-
Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
-
Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 84(1):339-43 (1994).
-
(1994)
Blood
, vol.84
, Issue.1
, pp. 339-343
-
-
Dover, G.J.1
Brusilow, S.2
Charache, S.3
-
82
-
-
0031889082
-
A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function
-
Rubenstein RC, Zeitlin PL. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am J Respir Crit Care Med 157(2):484-90 (1998).
-
(1998)
Am J Respir Crit Care Med
, vol.157
, Issue.2
, pp. 484-490
-
-
Rubenstein, R.C.1
Zeitlin, P.L.2
-
83
-
-
0032709471
-
Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia
-
Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol 62(4):221-7 (1999).
-
(1999)
Am J Hematol
, vol.62
, Issue.4
, pp. 221-227
-
-
Hoppe, C.1
Vichinsky, E.2
Lewis, B.3
Foote, D.4
Styles, L.5
-
84
-
-
0034796871
-
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule
-
Carducci MA, Gilbert J, Bowling MK, Noe D, Eisenberger MA, Sinibaldi V, et al. A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin Cancer Res 7(10):3047-55 (2001).
-
(2001)
Clin Cancer Res
, vol.7
, Issue.10
, pp. 3047-3055
-
-
Carducci, M.A.1
Gilbert, J.2
Bowling, M.K.3
Noe, D.4
Eisenberger, M.A.5
Sinibaldi, V.6
-
85
-
-
0034885248
-
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies
-
Gilbert J, Baker SD, Bowling MK, Grochow L, Figg WD, Zabelina Y, et al. A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies. Clin Cancer Res 7(8):2292-300 (2001).
-
(2001)
Clin Cancer Res
, vol.7
, Issue.8
, pp. 2292-2300
-
-
Gilbert, J.1
Baker, S.D.2
Bowling, M.K.3
Grochow, L.4
Figg, W.D.5
Zabelina, Y.6
-
86
-
-
12444321545
-
Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously
-
Kelly WK, Richon VM, O'Connor O, Curley T, MacGregor-Curtelli B, Tong W, et al. Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. Clin Cancer Res 9(10 Pt 1):3578-88 (2003).
-
(2003)
Clin Cancer Res
, vol.9
, Issue.10 PART 1
, pp. 3578-3588
-
-
Kelly, W.K.1
Richon, V.M.2
O'Connor, O.3
Curley, T.4
MacGregor-Curtelli, B.5
Tong, W.6
|